Neurothrombectomy: Improving Stroke Outcomes
The results of the latest studies utilizing advanced brain imaging technology are changing the stroke treatment guidelines. The DEFUSE 3 study expands on the results of the MR CLEAN and DAWN studies, and allow for extended window for thrombectomies to as long as 24 hours in some cases. It also broadens the population eligible for clot-busting medication to people with mild strokes.
Neurothrombectomy: Improving Stroke Outcomes is an expanded education initiative comprising of three webinars that focuses on the latest research results and improving stroke outcomes.
For more information and to view the webinars, click here.